Marex Group Ltd·4

Jul 15, 4:05 PM ET

Tonucci Paolo 4

4 · Marex Group Ltd · Filed Jul 15, 2026

Research Summary

AI-generated summary of this filing

Updated

Marex (MRX) Chief Strategist Paolo Tonucci Sells Shares

What Happened

  • Paolo Tonucci, Chief Strategist and CEO, Capital Markets at Marex Group Ltd, sold a total of 16,666 ordinary shares on July 13, 2026 via open-market/private sales (Form 4, code S).
  • The sales broke down as: 11,850 shares at a weighted avg $64.22 for $761,058; 4,584 shares at a weighted avg $64.85 for $297,271; and 232 shares at a weighted avg $65.73 for $15,249 — total proceeds $1,073,578. This was a sale (not a purchase or option exercise).

Key Details

  • Transaction date: July 13, 2026; Form 4 filed July 15, 2026 (appears within the typical 2-business-day window).
  • Reported prices and ranges:
    • 11,850 shares reported at $64.22 (sold in trades ranging $63.645–$64.645).
    • 4,584 shares reported at $64.85 (sold in trades ranging $64.65–$65.57).
    • 232 shares reported at $65.73 (sold in trades ranging $65.715–$65.75).
      The filer offers to provide a full breakdown of shares sold at each price on request (per the footnotes).
  • Shares owned after transaction: not specified in this Form 4. The filing notes that reported holdings include 220,746 shares underlying deferred bonus awards previously granted to the Reporting Person.
  • Notable footnotes: F1 — sale effected pursuant to a Rule 10b5-1 trading plan entered Oct 22, 2025; F2–F4 — weighted-average price ranges with offer to disclose per-price breakdown; F5 — includes deferred bonus awards.

Context

  • The sale was executed under a Rule 10b5-1 plan, a pre-arranged program that allows insiders to sell shares according to a preset schedule. Such plan-based sales are commonly viewed as routine and do not by themselves indicate a change in the insider’s view of the company.
  • For retail investors: purchases by insiders typically carry more informational weight than routine sales; this filing documents a scheduled sale totaling about $1.07M rather than an opportunistic purchase.

Insider Transaction Report

Form 4
Period: 2026-07-13
Tonucci Paolo
See Remarks
Transactions
  • Sale

    Ordinary Shares

    [F1][F2]
    2026-07-13$64.22/sh11,850$761,0581,287,093 total
  • Sale

    Ordinary Shares

    [F1][F3]
    2026-07-13$64.85/sh4,584$297,2711,282,509 total
  • Sale

    Ordinary Shares

    [F1][F4][F5]
    2026-07-13$65.73/sh232$15,2491,282,277 total
Footnotes (5)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $63.645 to $64.645, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $64.65 to $65.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $65.715 to $65.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The number of ordinary shares reported herein includes 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Signature
/s/ Scott Linsley as Attorney-in-Fact, for Paolo Tonucci|2026-07-15

Documents

1 file
  • 4
    ownership.xmlPrimary

    4